Direct immunofluorescence for autoimmune bullous diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
Highlighting MML Regional Service Representatives - Insights
Our Mayo Medical Laboratory regional service representatives provide outstanding support to our clients and have the opportunity to share the Mayo Clinic mission and expertise with laboratories around the world. To gain a good understanding...
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Lessons from Leaders: Who Let the DOGs Out? - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing, interviews Amy Clayton, M.D., Division Chair of Anatomic Pathology at Mayo Clinic, about "disease-oriented groups," which are multidisciplinary teams formed to establish a...
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
Winter Activities: Safety Tips - Insights
Here in Minnesota, we have entered into the time of year that is either loved or hated by Minnesotans: winter. In honor of Winter Hazard Awareness Week, November 6–10, Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, suggests resources...
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Frequently asked questions - Insights
Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.
Frequently asked questions - Insights
Read answers to frequently asked questions about prenatal testing at Mayo Clinic Laboratories, including specimen requirements, maternal cell contamination testing, pricing, and more.
Biopharma only testing - Insights
Find out how our suite of BioPharma Diagnostics-specific neurology testing can provide answers for your patients.
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Browse our full menu of individual tests and panels that aid in the diagnosis of tick-borne diseases.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Our renal diagnostics are backed by a multidisciplinary approach and an award-winning team of Mayo Clinic nephrology experts, pathologists, and laboratory scientists who work at the intersection of research and patient care.
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
An uncommon antibody, a life restored: Jori Pearson - Insights
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.
Thankful for Tygh: The Derossett Family - Insights
A Mayo Clinic Laboratories newborn screening panel detects a rare disease and paves the way for life-sustaining treatment.
Clinical excellence - Insights
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.
Transformative diagnostics - Insights
With a sophisticated laboratory test catalog and thousands of Mayo Clinic experts, we’re here to help you answer the toughest clinical questions.
Compassionate, knowledgeable death care brings Mayo Clinic's mission full circle - Insights
The Office of Decedent Affairs plays a key role in Mayo Clinic’s mission as its staff guide families through the logistics and complexities of a loved one’s death with skill and empathy.
An emotional proposition for a pancreatic cancer survivor: Jim Smith - Insights
Since overcoming a life-threatening diagnosis five years ago, Jim Smith has embraced life. But each time he travels to Mayo Clinic for follow-up laboratory testing, a well of emotions rises up to remind him of life’s fragility. Thankfully,...
Detecting danger: Dan O'Bryan - Insights
Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.
Next-generation sequencing: Examining an often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Sarcoma Informative Cases - Insights
Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can
MCL Therapeutics Test Request Form MC076719
MCL Therapeutics Test Request Form Complete print Reset Form Therapeutics Test Request Client Information required Client Client Account Client Phone Street Address
What's New in Health Care Reform: Jan. 23 - Insights
Top highlights include: Physician burnout now essentially a public health crisis, Americans more likely to die from opioid overdose than in a car accident, study identifies biomarkers to stratify patients for prostate cancer treatment, the...
What's New in Health Care Reform: Jan. 30 - Insights
Top highlights include: Alcohol overtakes Hepatitis C as the top reason for liver transplants, new research call vitamin D benefits into question, NIH funds first artificial pancreas study in the United States for pregnant women, cervical...
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Staffing to Workload in Phlebotomy Areas: Direct Effort - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on direct effort through time spent with a patient or patient sample.
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our staff, our stories: Ahmed and Alison Bashier - Insights
Looking back on their wedding, the Bashiers feel the event was a shining example of how greater empathy and understanding can be fostered between two very different cultures via a communal exchange of customs and traditions on an intimate...
Applying the Staffing-to-Workload Methodology: On-Site and Off-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses the inclusion of on-site and off-site operational needs of the laboratory in his staffing-to-workload analysis.
What's New in Health Care Reform: Feb. 13 - Insights
Top highlights include: College education doesn't protect against Alzheimer's, A.I. shows promise as a physician assistant, how machine learning is crafting precision medicine, CVS introduces new concept store with more health care, and...
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
BioPharma Diagnostics - Insights
BioPharma Diagnostics bring Mayo Clinic quality and expertise to collaborative engagements with biopharma, diagnostic and biotech companies to support a range of services, including clinical trial development, assay development, research...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
Mayo Clinic Laboratories’ nephrology experts, pathologists, and laboratory scientists uphold the highest standards of renal laboratory care.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...